1. Can serum biomarkers predict the outcome of systemic immunosuppressive therapy in adult atopic dermatitis patients?. Issue 1 (7th January 2022) Authors: Hurault, G.; Roekevisch, E.; Schram, M. E.; Szegedi, K.; Kezic, S.; Middelkamp‐Hup, M. A.; Spuls, P. I.; Tanaka, R. J. Journal: Skin health and disease Issue: Volume 2:Issue 1(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cytokine profiles in interstitial fluid from chronic atopic dermatitis skin. (18th May 2015) Authors: Szegedi, K.; Lutter, R.; Res, P.C.; Bos, J.D.; Luiten, R.M.; Kezic, S.; Middelkamp‐Hup, M.A. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 29:Number 11(2015:Nov.) Page Start: 2136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effect of immunosuppressive treatment on biomarkers in adult atopic dermatitis patients. (5th February 2020) Authors: Roekevisch, E.; Szegedi, K.; Hack, D.P.; Schram, M.E.; Res, P.C.J.M.; Bos, J.D.; Leeflang, M.M.G.; Luiten, R.M.; Kezic, S.; Spuls, P.I.; Middelkamp‐Hup, M.A. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 34:Number 7(2020) Page Start: 1545 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗